Actively Recruiting
Concentrated Exposure and Response Prevention for Children With Obsessive-compulsive Disorder
Led by Uppsala University Hospital · Updated on 2024-10-01
20
Participants Needed
1
Research Sites
274 weeks
Total Duration
On this page
Sponsors
U
Uppsala University Hospital
Lead Sponsor
U
Uppsala University
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this clinical trial is to evaluate the preliminary outcomes of concentrated exposure and response prevention for children with obsessive-compulsive disorder (OCD) in regular clinical practice. It is a non-randomised open label evaluation where children 6-12 years with OCD who are patients at the Child and Adolescent Psychiatry (CAP) at Uppsala University Hospital will be rectruited together with their legal guardians. The treatment will be delivered by trained therapists in regular outpatient care. The main question the study aims to answer is: What are the preliminary treatment effects of concentrated exposure and response prevention with regards to OCD-symptoms, functional impact, family accomodation and clinician ratings of severity and improvement? Participants will receive psychoeducation (in group format) and exposure and response prevention (9-12h concentrated to one week, individual format). Outcomes will be measured on structured interviews, clinician ratings, and validated questionnaires pre-treatment, post-treatment and at a six month follow-up.
CONDITIONS
Official Title
Concentrated Exposure and Response Prevention for Children With Obsessive-compulsive Disorder
Who Can Participate
Eligibility Criteria
You may qualify if you...
- The patient fulfills the diagnostic criteria of obsessive-compulsive disorder
- The patient and the legal guardians have said yes to receiving the concentrated exposure with response prevention treatment
You will not qualify if you...
- The patient or legal guardians are unable to communicate in Swedish
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Uppsala University Hospital
Uppsala, Region Uppsala, Sweden, 751 85
Actively Recruiting
Research Team
V
Vendela Zetterqvist, Ph D, Associate professor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here